Kairos Ventures
ActiveOverview
Kairos Ventures is a venture capital investment firm founded in 2015 that focuses on commercializing scientific discoveries and technological innovations into viable businesses. The firm invests primarily in the healthcare and technology sectors, backing early-stage companies from leading universities and scientists with investment amounts ranging from $150,000 to $20 million. The firm manages a portfolio of over 50 active companies spanning life sciences and physical sciences, positioning itself as an investor in ideas, patents, and businesses with transformative potential.
History
Kairos Ventures was founded in 2015 as a California-based venture capital firm. The company is led by a team of entrepreneurs with over 100 years of collective experience in building and managing businesses across diverse industries. By 2021, the firm had closed its third major fund, Kairos Venture Partners III. The firm has expanded internationally, launching Kairos Ventures ESG One, a sustainability-focused venture fund targeting the Italian market with a €100 million funding target.
Product Lines
| Product Line | Positioning | Price Range |
|---|---|---|
| Early-Stage Venture Investments | Pre-seed to Series A funding for scientific discoveries | $150,000 - $20,000,000 |
| Life Sciences Portfolio | Healthcare and biotech company investments | $150,000 - $20,000,000 |
| Physical Sciences Portfolio | Technology and materials science investments | $150,000 - $20,000,000 |
| Kairos Venture Partners III | Institutional venture capital fund | Institutional scale |
| Kairos Ventures ESG One | Sustainability-focused venture fund for Italian market | €100 million fund target |
Manufacturing
As a venture capital firm, Kairos Ventures does not manufacture physical products. Instead, the firm provides capital and strategic support to portfolio companies that develop and manufacture their own products and technologies. The firm works closely with scientists and entrepreneurs to commercialize technologies from leading universities and research institutions.
Notable Products
- Wonder Blades - Portfolio company developing proprietary Bulk Metal Glass razor blades targeting the $10 billion razor blade industry
- Amorphology - Portfolio company specializing in bulk metal glass materials technology
- 1200 Pharma - Life sciences portfolio company in pharmaceutical development
Reputation
Kairos Ventures is recognized as a serious venture capital investor focused on science-backed innovation and commercialization. The firm's strength lies in its team's extensive entrepreneurial experience and its ability to work directly with leading scientists and universities to identify promising technologies. The firm has established credibility through its growing portfolio of over 50 active companies and its expansion into international markets with sustainability-focused initiatives. As a relatively younger venture firm founded in 2015, it operates in a competitive market dominated by larger, more established venture capital firms.